Back to Top

Information For Authors

Medical Acupuncture is a journal with an international scope, focusing on the evolving specialty of medical acupuncture. The editor welcomes articles on all aspects of medical acupuncture, including research, education, clinical practice, technology, policy, ethics, law, schools of thought, history, and related disciplines.

MANUSCRIPT SUBMISSION

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

All new manuscripts must be submitted online at: http://mc.manuscriptcentral.com/acupuncture. Please read ALL “the Instructions for Authors” before submitting; all papers must also adhere to the new STRICTA 2010 requirements (available online: http://www.stricta.info/

Please upload individual files of all manuscript materials—do NOT upload a single PDF file containing all text, figure, and table files of your article. Once all individual files are uploaded onto Manuscript Central, the system will automatically create a single PDF proof for you, and the peer-review process.

All material submitted should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as formulated by the International Committee of Medical Journal Editors. These requirements appear in their entirety (updated October 2007) online at www.icmje.org/index.html  Note the requirement for the registration of clinical trials.

Please adhere to the new STRICTA 2010 (Standards for Reporting Interventions in Controlled Trials of Acupuncture), requirements available online at www.stricta.info/

Authorship

All persons designated as authors must qualify for authorship. Criteria include substantial contributions to the following: (a) conception, design, and/or analysis and interpretation of data; (b) writing or revising the manuscript for intellectual content; and (c) final approval of the paper for publication. All 3 criteria must be met. Contributors who do not meet these 3 criteria should be listed, with their permission, in an acknowledgement paragraph.

The order of the author byline should be reached by consensus of the co-authors. All authors should be listed by full name, one major degree, and affiliations along with other pertinent information.
 

Biographical and contact information (including address, phone and fax numbers, email address) for all authors must be provided.

Once material is published in the Journal, it becomes the copyrighted property of Mary Ann Liebert, Inc. Permission must be obtained from Mary Ann Liebert, Inc. to publish in other medical journals.

 

The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.

 

It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including the page proof stage – are NOT permitted. Changes in authorship after publication are strictly prohibited.

 

Financial Disclosure

All affiliations with, or financial involvement in, any entity with a financial interest in, or in competition with the article’s subject matter must be disclosed. This includes stock ownership, employment, consultancies, honoraria, grants, patents, and royalties.

 

Redundant or Duplicate Publication.  Medical Acupuncture does not publish articles that have been submitted or published elsewhere.

 

Informed Consent, Study Ethics Approval, and Subject Confidentiality

When articles include reports of studies on human subjects, state in the Methods section that an appropriate review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki (2013). In the Methods section, state that informed consent was obtained from subjects (specify oral or written).

In addition, text, photographs, and pedigrees should not reveal identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.

Animals. The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and conformed to the standards of current ethical animal research practices.

 

Note: when uploading your figures and tables, please label them with the journal acronym, ACU, and the year, plus your last name and the figure number. Example: ACU.2008.Smith.Fig1. 

PLEASE ENSURE THAT YOUR MAIN MANUSCRIPT TEXT FILE CONTAINS THE FOLLOWING:

  • A title page which includes the title of the article, as well as ALL authors’ names, affiliations, email addresses, and contact information.
     
  • An abstract (uploading your abstract into the appropriate field in Manuscript Central will NOT automatically incorporate it into the text file, so please include the abstract within the manuscript file).
     
  • References section correctly formatted (see examples).
     
  • Tables and figures should be uploaded as individual files.
     
  • Do NOT upload a PDF of your text file. 

NOTE:  Supplemental Information / Files will not be copyedited or typeset; they will be posted online-only as they were supplied.

 MANUSCRIPT PREPARATION

Title Page

Note that the new STRICTA 2010 requirements require that you identify the type of trial: that is Acupuncture for hiccups in the elderly adult: a randomized trial; Acupuncture used to stop smoking: an observational trial. The title page should include the full article title, names and affiliations of all authors, and corresponding biographical information for all authors, including mailing address, fax and telephone numbers, and email addresses. (Example John K. Jones, MD [Main credential only])

Abstract

For original research, reviews, and meta-analyses, provide a structured abstract of no more than 250 words. Include information as applicable for the following headings: Background, Objective, Design, Setting, Patients (or Subjects), Intervention, Main Outcome Measures, Results, Conclusions, Randomizations (If applicable, elaborate), Blinding (Investigators and Subjects), Conclusions, Registration and Funding. For all other major manuscripts, include an unstructured abstract of no more than 250 words that summarizes the objective, main points, and conclusions of the article.

Key Words

Underneath the abstract, provide 3–10 key words (preferably Medical Subject Heading (MeSH) terms) that will assist indexers and researchers using electronic databases such as MEDLINE

Text

Introduction. Note Table 2/2ab new STRICTA 2010 (http:// www.stricta.info/) Provide a brief background for the article, including the rationale and hypothese for the study or observation. Do not present data from the current work.


Methods. The following should be taken into account:

1. Provide rationale for treatment, and style of acupuncture used.

2. Supply needling details: unilateral/bilateral points employed.

3. Number of needles inserted; needle type (gauge, length, manufacturer [include city, state, and country]); insertion depth; responses elicited (Qi); and whether twirled counterclockwise or clockwise.

4. Electrostimulator device (type, model, manufacturer [include city, state, and country]); time; stimulation frequency; which leads are designated negative and positive and where placed.

5. State treatment regimen: number of treatments, frequency (treatments per week, etc.); interventions employed such as moxibustion, cupping, herbs, etc.; treatment duration; environment: music, lighting, aromatics, etc.

Describe the selection of subjects, including demographics and study design. Describe the location and dates of the study. Identify the procedures in sufficient detail so others may replicate the results. Provide references to established methods and new techniques; provide the rationale for their use and also describe their limitations. Authors submitting review articles should describe the methods used to locate, select, extract, and synthesize data.

The principal author must state that verbal or written consent was obtained from the patient(s) when appropriate. The principal author must state whether a human research committee granted approval for treating and obtaining data or employing protocols that involved human subjects.


Statistics. As necessary, describe statistical methods and provide appropriate indicators of error or uncertainty (e.g., 95% confidence intervals). Specify any statistical software used.

Your article must follow as appropriate the sequence below which is the new STRICTA 2010 requirements.

METHODOLOGY:

The italicized 1–6 below is information that must appear in the METHODOLOGY. This is found in Table 1 of the new STRICTA 2010.

1. Acupuncture rationale 1abc as appropriate
2. Details of needling 2(a) to 2(g)
3. Treatment regimen 3ab
4. Other components of treatment 4ab
5. Practitioner Background 5
6. Control or Comparator interventions 6ab

Use the new STRICTA 2010 Table 2 to complete the METHODOLOGY section:

A. TRIAL DESIGN 3ab
B. PARTICIPANTS 4ab
C. INTERVENTIONS 5
D. OUTCOMES 6ab
E. SAMPLE SIZE 7ab

Use the new STRICTA 2010 Table 2 to complete the RANDOMIZATION section:

RANDOMIZATION

A. Sequence generation 8ab
B. Allocation Concealment 9
C. Implementation 10
D. Blinding 11ab
E. Statistical methods 12ab

Results. Present results in a logical sequence. Do not duplicate data in the text and tables/figures.

Use the new STRICTA 2010 Table 2 to complete the RESULTS section.

RESULTS

A. Participant flow 13ab
B. Implementation
     Recruitment 14ab
     Baseline data 15
     Numbers analyzed 16
     Outcomes and Estimations 17ab
     Ancillary Analyses 18
     Harms 19

 

Discussion. The discussion section should summarize the results and their implications. This section should also discuss the rationale of acupoints used such as mechanisms of action; clinical implications and usefulness; and benefit to the patient.

 

Conclusion(s).  Summarize the paper’s findings and their importance.  This text may also give rise to questions, discuss ambiguous data, and recommend areas of further research.


Use the new STRICTA 2010 Table 2 to complete the DISCUSSION and OTHER INFORMATION sections. Note that we require a CONCLUSIONS section.

 

DISCUSSION

A. Limitations 20
B. Generalizability 21
C. Interpretation 22

 

OTHER INFORMATION

A. Registration 23
B. Protocol 24
C. Funding 25

Many of the articles in our journal are singular case reports. In achieving publications of these articles it is obvious that some components of STRICTA may not be applicable. Nevertheless we need to strive and maintain the quality of this journal. We urge you to plan your articles carefully and remember a single case is interesting, but not conclusive and subjected to much scrutiny especially by the Editor-in-Chief and the reviewers.

 

Nomenclature and Abbreviations

Authors must conform to the standard nomenclature for medical acupuncture, listed at the end of these instructions. As a general rule, use only these abbreviations and those easily recognizable in the literature. The full term should appear at first mention, followed by the abbreviation in parentheses. Standard units of measure are acceptable to abbreviate without expansion. When discussing particular products, it is preferable to use the nonproprietary (generic) name or descriptive term throughout. If desired, the brand name can be included parenthetically at first mention.

 

Acknowledgments

At the end of the article, include a paragraph, when appropriate, acknowledging support for the work. It can include contributions that do not justify authorship, technical support, and financial and technical help. This is also an appropriate place to mention previous presentations (e.g., as an abstract or poster at a meeting).

Author Disclosure Statement

Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” This text must be part of your actual manuscript file
. In this portion of the article, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the article is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist.”

References
Cite references within the text using superscript Arabic numbers (e.g., “as previously described.”1,4) List references in text in numerical order. Do not use “ibid,” but instead repeat the number of the citation. The reference list at the end of the article should be double-spaced and organized by Arabic numbers. Use journal abbreviations as provided by MEDLINE.® List all authors up to 6 authors. If there are more than 6 authors, list 3 and then et al. If references to personal communications or unpublished data are used, they are not to be included in the list of references. They should be referred to in the text in parentheses, including date. Include, among the references, articles accepted but not yet published; provide the journal, title, and the designation “In press.” If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the references, and are reminded that inaccurate and dishonest references are highly frustrating to the reader, the cited author, and indexing services. Please follow the samples below. Translate titles of articles into English and place the original language in brackets.

Sample References: Journal article: Jobst KA. Acupuncture in asthma and pulmonary disease: an analysis of efficacy and safety. J Altern Complement Med. 1996;2(6):179–206.

Book: Ersser SJ. Nursing as a Therapeutic Activity: An Ethnography. Avebury, UK: Aldershot; 1997:371.

Edited book: Fulford KWM, Ersser SJ, Hope T, eds. Essential Practice in Patient-Centered Care. Oxford, UK: Blackwell Science; 1996.

Chapter in a book: Van Wijk R, Wiegant FA. Physiological effects of homeopathic medicines in closed vials: a critical evaluation. In: Endler PC, Schulte J, eds. Ultra High Dilution Physiology and Physics. Boston, MA: Kluwer Academic Publishers; 1994:81–98.
Abstract: van der Hamm IJ, Raemaekers M, van Wezel RJ, et al. Categorical and coordinate spatial relations in working memory: an fMRI study [abstract]. Brain Res. July 2009. doi:10.1016/j.brainres.2009.07.088.
Website: Include name of website, and URL, starting with www. Include month, day, and year accessed.

A minimum of 3 references is required. References should be numbered consecutively in the text; do not alphabetize the reference list, but present citations in numerical order to correspond with mention in the text. References cited only in tables or figures should be numbered in accordance with the order established by the first mention of that table or figure in the text.

Avoid citing “personal communications” unless they provide essential information; do not list them in the references but place them parenthetically in the text. Authors should obtain permission from the source of such communications and indicate the date they occurred and whether the communication was oral or written. Also include the first name, surname, and degree of the source.

 

Tables
Do NOT include tables or figures within your text file. All tables should be prepared in one collective file, preferably with one table to a page. Upload single file containing all tables to Manuscript Central as "Table(s)" under file designation. Number tables consecutively in the text as they appear. Provide a title for each table, as well as column headings. Be sure to cite all table(s) in text. Provide footnotes for explanatory material, using the following symbols in sequence: * † ‡ § ||  #. Identify statistical measures, such as mean (SD). Data from other sources require permission and a statement of such in a table footnote. The use of too many tables in relation to length of text may cause problems for journal page layout. Avoid duplicating data in text and tables/figures, with the exception of main outcomes.


Figures
Do NOT embed figures in the text file. Letters, numbers, and symbols should be clear and of sufficient size when printed in the Journal.  If pictures of patients are used, either the subjects must be completely unidentifiable or written informed consent must be obtained and submitted.

Electronic submission of figures is permitted with the following caveats:

 

• Do NOT include any illustrations as part of your text file.
• Do NOT prepare any figures in Word as they are not usable.
• Line illustrations must be submitted at 600 dots per inch (dpi).
• Halftones and color photos should be submitted at a minimum of 300 dpi.
• Do not submit PowerPoint files.
• Save art as either .TIFF or .EPS files. Avoid submitting .jpg files.

• Color art must be saved as CYMK, not as RGB.

  • Name figure files using only alphanumeric characters.  Do not use symbols, dots, or dashes.
  • File names should be formatted with first author’s last name and the figure number. (Ex:  SmithFig1)

Figures reprinted from other sources should be acknowledged in the legend, and permission must be granted. The legend should be submitted as part of the text and not typed on the actual figure. Clearly identify all symbols and abbreviations, and explain scales if necessary. Any other explanatory information should be given in the legend.

 

Submission and Editing Process

All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Medical Acupuncture.  For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage.  The Publisher offers this service with a subsidy from the author prior to official submission (contact:  AuthorServices@liebertpub.com).  It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any paper.  All submissions are subject to peer review. The Journal prefers that the article be composed using a 12-point font in Microsoft Word.  All accepted submissions are subject to copyediting.

 

Submit all manuscript components ONLINE via Manuscript Central at:http://mc.manuscriptcentral.com/acupuncture  The author’s request to withdraw the manuscript after undergoing the editing process will result in possible penalty fees based on editing costs, and possible exclusion from future publishing in Medical Acupuncture.

 

Manuscript Review Process

Each manuscript will be initially reviewed by the Editor-in-Chief for preliminary acceptance or rejection. The manuscript is then forwarded to appropriate experts for review and scored appropriately (peer review). The manuscripts are categorized as fully accepted, accepted pending revisions, or rejected with recommendations for re-submission. After submission, no revisions or new versions will be accepted unless requested by the Editor-in-Chief.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

 

STANDARD NOMENCLATURE FOR MEDICAL ACUPUNCTURE

READERS: The standard nomenclature was revised May 2002.

The following names and abbreviations are to be used in Medical Acupuncture. Recent changes in nomenclature have been adopted by the American Academy of Medical Acupuncture (AAMA) and are to be used in all articles submitted to the Journal. Please pay strict attention to these changes. For the most part, this is the system endorsed by the World Health Organization (WHO). Common English anatomical, physiological, and pathological terms are capitalized to indicate their Chinese medical meanings, for example, Lung, Blood, Heat Deficiency, etc. The Alphabetic Code was agreed on by participants and observers at a meeting of the WHO Scientific Group held in 1989.

STANDARD INTERNATIONAL NOMENCLATURE FOR MERIDIANS

Name of Meridian            Alphabetic Code

Principal Meridians

Lung Meridian                               LU
Large Intestine Meridian             LI
Stomach Meridian                        ST
Spleen Meridian                           SP
Heart Meridian                              HT
Small Intestine Meridian             SI
Bladder Meridian                          BL
Kidney Meridian                            KI
Pericardium Meridian                  PC  
Triple Energizer Meridian           TE
Gallbladder Meridian                  GB
Liver Meridian                               LR
Governor Vessel (Dumai)          GV
Conception Vessel (Renmai)   CV
 

Extra Meridians

GV                         Dumai                        Governor Vessel
CV                         Renmai                      Conception Vessel
TV                         Chongmai                  Thoroughfare Vessel
BV                         Daimai                        Belt Vessel
YinHV                   Yinqiaomi                   Yin Heel Vessel
YangHV               Yangqiaomai             Yang Heel Vessel
YinLV                    Yinweima                   Yin Link Vesseli
YangLV                Yangweimai               Yang Link Vessel 

 

Miscellaneous 

Fu                                                   Hollow organs
Zang                                              Solid organs
Front Mu                                       Collecting points
Back Shu                                      Transporting points
Sheng                                           Generating cycle
Ke                                                  Controlling cycle
Ah Shi                                           “Ouch” point
De Qi                                             Arrival of Qi
 

Command and Special Points

Ting                                     Well    
Ying                                 Spring    
Shu                                Stream    
Jing                                   River  
He                                       Sea  
Yuan                              Source
Luo                                Vessel
Xi                                        Cleft 
Hui                            Influential

Energy Levels or Axes

Tai Yang                        Tai Yin
Shao Yang                Shao Yin
Yang Ming                    Jue Yin
 

 

 

RESPONDING TO ALLEGATIONS OF POSSIBLE MISCONDUCT

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

DEFINITIONS OF SCIENTIFIC MISCONDUCT

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  • Authorship Disputes: Deliberate misrepresentation of a scientist's contribution to the published work, or purposefully omitting the contributions of a scientist.
  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
  • Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another's work or idea as your own constitutes misconduct and/or fraud.
  • Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
     

    PUBLISHER

    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801. Telephone: (914) 7402100; Fax: (914) 740-2101; Email: info@liebertpub.com; Website: www.liebertpub.com

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email openaccess@liebertpub.com.

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Browse journals in the Liebert Open Access portfolio:

JOURNAL FEES

  • There are no submission fees to Medical Acupuncture.
  • There no page charges for Medical Acupuncture.
  • Please contact AuthorBenefits@liebertpub.com for costs for publishing images in color.
  • Open Access and Creative Commons licensing options are available. Contact our Open Access Manager for more information.
  • For pricing and purchasing reprints, contact our Reprints Manager.
  • Any fees collected or payments associated with a submitted and/or published paper that is subsequently withdrawn and/or retracted for any reason are non-refundable.

All Mary Ann Liebert, Inc. journals follow the standards, guidelines, and best practices set forth by the -Committee on Publication Ethics (COPE; publicationethics.org), the International Committee of Journal Medical Editors (ICJME; www.icmje.org), the World Medical Association (WMA); www.wma.net) and the American Medical Association (www.ama-assn.org).

Medical Acupuncture is a single-blinded peer-reviewed journal. All submissions are subject to peer review. Upon submission, manuscripts are assessed by an editor for suitability for the journal.  For those that are deemed suitable, a minimum of 1-2 expert reviewers in the area of study will be selected to assess the scientific basis and significance of the manuscript. Following peer review, the Editor and/or Associate Editors will determine if the paper should be accepted, require revision, or is unacceptable for publication.

Confidentiality in Peer Review

Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Sharing a manuscript in whole or in part, outside the scope of what is necessary for assessment, is impermissible prior to an accepted manuscript's official publication date.

Sharing of Materials during Peer Review

Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects.

Papers Authored by the Editor-in-Chief and/or Associate Editors

The Editor-in-Chief and Associate Editors will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest.

Self-Citation and Self-Plagiarism

Medical Acupuncture is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works. (Deposition of a preprint on a preprint server is not considered as prior publication and will not impact consideration of any submitted manuscript.)

Time in Review

Medical Acupuncture aims to maintain a short, but thorough peer-review process. The average time in review is 28 days.  However, the Editor(s) will strive to expedite manuscript handling if/when special circumstances dictate.

ATTENTION:  To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.
 

AUTHORSHIP

Definition of Authorship

Authorship, as defined by the International Committee of Medical Journal Editors, is based on the following criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Non-Author Contributors

Contributors who meet fewer than all four of the above criteria for authorship should not be listed as authors, but they should be acknowledged in the Acknowledgments section with a description of their contribution to the work.

For further information, visit the International Committee of Medical Journal Editors’ website at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

ORCID IDs

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

AUTHORSHIP LIMIT

There is a limit of 35 of authors permitted on a single submission, but in cases where there are 20 or more co-authors, Medical Acupuncture recommends that a collective group or consortium name be provided and the individual authors listed in the Acknowledgements.

CORRESPONDING AUTHOR**

One author should be designated as the corresponding author who will be responsible for communication between the authors and the journal editorial office(s) and publisher. This individual will be responsible for ensuring all authors submit copyright forms and coordinating and responding to page proofs, as well as any managing any other necessary contact during the peer review and/or production processes.

**NOTE: Due to configuration restraints, the submission system permits only one author to be identified as the corresponding author of record. However, we recognize that some submissions call for more than one corresponding author to be noted. In such cases, select one author to be the main point of contact and/or corresponding author for all communications regarding the peer review process of the paper, but on the title page of the manuscript, designate additional co-corresponding authors by including an asterisk after the authors' names in the byline, and include an accompanying footnote on the title page that reads, "*Co-corresponding authors."  Please ensure that the title page of the submission page carries the full affiliation details and email addresses of all authors who should be noted as a corresponding author. If the paper is accepted for publication, the full contact information for all desginated co-authors will be listed at the end of the article as per usual journal style.

WORKING GROUPS / TEAM AUTHORSHIP

Working Groups or Teams may be listed in the manuscript byline, but the entire listing of names and affiliations should be included in the acknowledgment section of the manuscript. Do not list the names in a footnote on the title page.

VARIATIONS OF AUTHORSHIP

It is permissible to list up to three authors as co-first authors, or as contributing equally to the work. Include an asterisk (*) next to the authors' names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, "These authors contributed equally to this work and are considered to be co-first authors."

CHANGES IN AUTHORSHIP

Changes in authorship after submission or acceptance of a paper are strongly discouraged, but the editorial leadership recognizes that in certain circumstances, it may be required. The journal's policy for such cases is as follows:

  • A request to alter authorship must be made in writing from the corresponding author to the Editor-in-Chief, with a detailed explanation for the request, and the names and affiliations of the authors requiring addition and/or deletion.
  • Authorship may be altered after submission or acceptance of a paper ONLY with the expressed written approval of all authors named on the manuscript, as well as the individual(s) being added and/or deleted. The Publisher can provide a form for this, if needed.
  • Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author.
  • There is a one-year post-publication statute of limitation on requests for alterations in authorship.
  • Post-publication changes or alterations to conference abstracts are prohibited.

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

EXCLUSIVITY

Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same form or substantially similar form, except in the form of a conference abstract.  If work was presented at a conference, supply the name, date, and location of the meeting as a footnote on the title page of the submission.

USE OF ENGLISH LANGUAGE

All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Medical Acupuncture. For authors whose native language is not English, we recommend using a service that will aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service for a fee prior to official submission. For more information, please contact: Editing@liebertpub.com Please note that employing the use of the Publisher's service is not required and using it, or any other language editing service, does not guarantee acceptance of any paper. All submissions are subject to peer review.

AUTHOR DISCLOSURE STATEMENTS

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

SELF-CITATION AND SELF-PLAGIARISM

Medical Acupuncture is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works.

AFFILIATIONS

Authors should identify as their institution(s) the facility where the work was performed and executed.  Changes in an author’s affiliation after the work was completed but prior to the submission or publication of the manuscript should be noted by including an asterisk as a superscript to the name in the author listing, as well as a corresponding footnote on the title page indicating “Current Address” listing the new affiliation.   Corrections to affiliations or contact information due to relocation after publication is not permitted.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

INTERNAL REVIEW BOARD APPROVALS/WAIVERS

(as described and defined on the World Medical Association's website; www.wma.net)

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and in a sentence declaring adherence should be included in the Materials and Methods section of the manuscript.

ETHICS OF EXPERIMENTATION

All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. (http://ethics.od.nih.gov/).

ETHICAL TREATMENT OF ANIMALS

All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.

For further information, consult the World Medical Association’s website: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

AUTHOR DISCLOSURE STATEMENTS

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

INTERNAL REVIEW BOARD APPROVALS/WAIVERS

(as described and defined on the World Medical Association's website; www.wma.net)

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and in a sentence declaring adherence should be included in the Materials and Methods section of the manuscript.

COPYRIGHT AGREEMENT FORM

Upon acceptance of any manuscript, all authors will receive an email with detailed instructions and a unique, author-specific link to access and complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors' email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications. FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION. The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright. Copyright forms may also be completed by logging in to the system using an author's credentials. After logging on, click on Author Center and complete the forms located under "Manuscripts I Have Coauthored."

Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc., unless alternate arrangements are made prior to publication, including CC-BY licensing (see below). By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.

OPEN ACCESS / CC-BY LICENSING

Medical Acupuncture is a subscription-based peer-reviewed journal with Open Access options. Creative Commons CC-BY and CC-BY-NC licensing is available for all articles published open access for a standard Article Processing Charge (APC) of $3,200.00 USD. Please contact our Open Access Manager to order open access for your article. Learn more about open access publishing on our website.

PERMISSIONS

When reproducing copyrighted material such as figures, tables, or excerpted text, the author(s) of the submitted paper must obtain permission from the original publisher and submit it concurrently with the manuscript. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote to a reprinted table or the legend of a reprinted figure should read, "Reprinted by permission from Jones et al." and list the appropriate reference. All permissions must be supplied at the time of submission.  Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources.

REUSE OF MATERIAL POSTED ON SOCIAL MEDIA

As material posted on social media platforms is usually not peer-reviewed content, it is not permitted as an official citation and/or reference.

Mary Ann Liebert, Inc., publishers permits the use of accepted pre-published manuscripts for the sole purpose of pitching to news organizations under strict embargo, and with the approval of and expressed collaboration with the publisher. A watermarked PDF version of the article (not a Word document or any other editable version) may be shared only with named, personal contacts at trusted news sources upon request. News sources must be informed upon delivery of the PDF that the manuscript is for reference-only purposes and can be used only in preparation of their news coverage of the article. It is strictly prohibited to publicly share, post, or otherwise distribute the PDF in any media format. Upon official publication of the article, news organizations must link directly to the published article on the publisher’s journal website. To coordinate publication timing and press efforts, please contact the Director of Marketing, Kathryn Ryan (kryan@liebertpub.com).

DATA SHARING

Medical Acupuncture strongly advocates the sharing and archiving of the data and any other artifacts that define and support the results stated in a manuscript in a suitable public repository (in accordance with valid privacy, legal, and ethical guidelines). A data availability statement should be included in the manuscript (in the Methods section or as a separate section at the end of the manuscript), describing the location of the data, with details on how it can be accessed as well as any licensing information. If the data is not publicly available or accessible, that information should also be provided.

Datasets should be cited in the reference list by Author (Year). Title. Publisher. Identifier/DOI.

Important: Please check with your funding agencies to ensure that are you following their data sharing polices. If your funding agency has additional requirements exceeding our policy, you must follow the requirements of your funder.

PREPRINT SERVERS

A preprint is a complete draft of a research paper that is shared on a public preprint server prior to submission to a journal for peer review.

 
Mary Ann Liebert, Inc., allows for papers that were previously deposited on preprint servers to be submitted to our journals, with the proviso that the author updates any preprint versions with a link to the final published article.  All submissions are subject to peer review and allowing the submission of preprint manuscripts does not guarantee publication in any Mary Ann Liebert, Inc., journal.
 
The submitting author of a paper that was previously deposited to a preprint server should include a disclosure on the title page of the manuscript indicating the name and website of the server and include the DOI number of the preprint.
 
Referencing/citing non-peer-reviewed material that is found on any preprint server is generally discouraged by Mary Ann Liebert, Inc., journals, but if it is necessary, the citation must make it clear that the content is not officially published in a journal, and can only be found on a preprint server.

 

RESEARCH FUNDER COMPLIANCE (FundRef)

Upon submission of a manuscript, the submitting agent will have an opportunity to enter funding/grant information. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata to FundRef. The entered information should include funder names, funder IDs (if available), and associated grant numbers.  Special care should be taken when entering this information to ensure total accuracy. (See https://www.crossref.org/services/funder-registry/ for a listing of more than 13,000 international funding agencies.)

GOVERNMENT FUNDED RESEARCH

Medical Acupuncture is fully NIH-, HHMI-, RCUK, and Wellcome Trust-compliant.

OPEN ACCESS

Our open access publishing solutions allow you to comply with the open access policies of your institution, government, and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK), or Howard Hughes Medical Institute (HHMI), you can find more information below:

  • NIH and HHMI Public Access Policy–In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final paginated version of the published article to PubMed Central (PMC) on behalf of the authors after a 12-month embargo period. Authors need not take any action. This service is provided free of charge. Authors who wish to remove the 12-month embargo period are encouraged to consider publishing with Open Option.
  • Wellcome Trust Policy–To easily comply, you can choose to have your article published open access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the Wellcome Trust.
  • Research Councils UK (RCUK)–To easily comply, you can choose to have your article published Open Access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the RCUK.

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

POST-ACCEPTANCE / PRODUCTION

All accepted manuscripts will go through copyediting, typesetting, figure sizing and placement, author proofing, corrections, revisions (from corrected proofs), online-ahead-of-print release, and lastly, issue assignment. Depending on the length and complexity of any accepted submission, these steps typically take 3-6 weeks from acceptance.  Changes or alterations to a submission are not permitted after acceptance, but should be addressed in page proofs.

PAGE PROOFS

Page proofs will be sent to the corresponding author as designated in Manuscript Central when the manuscript was submitted. It is the corresponding author's responsibility to share the page proofs with co-authors, if desired, and to coordinate all authors' corrections into one proof. The Publisher will not accept corrections from multiple authors/sources.

AUTHOR RESPONSE TO GALLEY PROOF

  • The corresponding author is responsible for returning corrected galley proofs generally within 72 hours of receipt.
  • If the corresponding author does not respond within that timeframe, the manuscript may be delayed in the publication schedule, or published as is, at the discretion of the Editor and Publisher.
  • If the corresponding author expects to be unavailable during the time the manuscript is in production, the publisher should be provided with an alternate contact. 
  • Only corrections directly related to errors in typesetting and/or layout will be allowed.
  • Any requested changes related to content, or that alter the outcome of a study, will require the approval of the Editor, and may require further peer review.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

POST-PUBLICATION CORRECTIONS

In the event an error is discovered after publication of an article, the corresponding author should submit the correction in writing to the editorial office for consideration.  After editor approval, alterations will be made to the online version of the article, and if the errors are significant, an official correction statement will be issued.

  • Changes to author affiliations or contact details due to relocation after publication are not permitted.
  • Corrections to meeting abstracts will be made only to the online version.  The Journal does not issue formal correction statements for corrections to meeting abstracts, regardless of the nature of the correction.
  • Correction Statements/Errata to published articles that require the reproduction of color figure(s) and/or table(s) may incur additional costs to the author(s).

RETRACTIONS**

The journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of the misconduct noted above, or in the accepted principles of peer review and scientific publishing, will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction.

**Any publication fees for retracted and/or withdrawn articles are nonrefundable in any circumstance.

Policy Statement:
Retraction Notices / Expressions of Concern

The Publisher is committed to protecting the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct appropriate investigations into any reported allegations. As such, all allegations of misconduct will be referred to the Editor-in-Chief of the Journal who in turn will review the circumstances, possibly in consultation with Executive Editors, Senior Editors, Associate Editors, and/or other members of the editorial board as needed.  Initial investigations and fact-finding will include a request to all involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-in-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an Editor, an outside expert. The Editor-In-Chief and/or the Publisher may consult with our Ethics Editor(s) and will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations arise, the peer review and publication process of the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the paper is withdrawn by the authors or Editor(s). In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.  If the paper is still under peer review, the Editor-in-Chief reserves the right to withdraw the paper from consideration to the Journal.

If the accusation is with regards to a published paper, the Journal/Publisher reserves the right to publish an official “Expression of Concern” statement while the investigation is still underway.  This statement will contain the full circumstances of the complaint and will be placed directly above the published Abstract in the online version of the article.  If the investigation is not resolved by the time the next print issue of the journal is to be published, the Expression of Concern will be published as official content in the print issue.

If the investigation determines clear misconduct, the Editor-in-Chief and Publisher will officially retract the paper from the Journal and the scientific record by publishing a formal Retraction Notice both online and in print. This notice will contain all relevant details of the accusation, investigation, and the resulting conclusions.

The official Retraction Notice will replace the abstract in the online version of the article as well as in the PDF.  In addition, each page of the PDF will be watermarked with “Retracted.” The Retraction will be delivered to all associated indexing services affiliated with said journal (i.e. PubMed Central, PubMed/MEDLINE, Web of Science, etc.).

In the case where an investigation determines that no misconduct occurred, the Expression of Concern will be updated accordingly but will remain intact as part of the article and will not be removed so that readers will be notified that concerns were raised.

Editors, authors, or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal and reported to their institution.

Every attempt will be made to keep all allegations confidential.

STUDY DESIGN AND ETHICS

RESPONDING TO ALLEGATIONS OF POSSIBLE MISCONDUCT

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

DEFINITIONS OF SCIENTIFIC MISCONDUCT

Mary Ann Liebert, Inc., publishers follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  • Authorship Disputes: Deliberate misrepresentation of a scientist's contribution to the published work, or purposefully omitting the contributions of a scientist.
  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
  • Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another's work or idea as your own constitutes misconduct and/or fraud.
  • Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.

RETRACTIONS

The journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of the misconduct noted above, or in the accepted principles of peer review and scientific publishing, will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction.

ARCHIVING AND PRESERVATION

Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Your article will be easily searchable on Google, Google Scholar, and other search engines.

PUBLISHER

Medical Acupuncture is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801; Tel: 914-740-2100; Email: Info@liebertpub.com; Website: www.liebertpub.com/ACU

The Office of Foreign Assets Control (OFAC) of the US Department of the Treasury administers and enforces economic and trade sanctions based on US foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. (Source: https://www.treasury.gov/about/organizational-structure/offices/pages/office-of-foreign-assets-control.aspx)

Our journal editors welcome contributions from researchers around the world; however, they are also required to follow sanction laws and regulations. Upon the date of this update (August 2020), sanction measures imposed by the United States, United Nations, European Union, and Australia are currently in place against the following countries: Cuba, Crimea, Iran, North Korea, and Syria. Journal editors will treat with caution any submission from a sanctioned country regarding the subject matter and will seek appropriate legal advice from the publisher if necessary.

Papers from sanctioned countries that are submitted to any Mary Ann Liebert, Inc., journal MUST contain a confirmation statement after the conclusion section of the manuscript which indicates that EACH listed author confirms that their research is supported by an institution that is primarily involved in education or research.

For further questions, please contact our Director of Production and Editorial Operations.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Society Affiliations

Upcoming Events

Jan 14 - Jan 16, 2021
Jul 02 - Jul 04, 2021